DR. NORRIS DUNEVANT M.D. NPI 1619911856

NPI Details

DR. Norris Dunevant, M.D. is a family medicine in Oro Valley, AZ with 29 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. DR. Norris Dunevant, M.D. NPI is 1619911856. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE
Graduation Year:1997

The provider's business location address is:

1521 E TANGERINE RD
STE 201
ORO VALLEY, AZ
ZIP 85755-225
Phone: (520) 825-2520
Fax: (520) 825-2501

The NPI 1619911856 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Hemoglobin a1c level (HCPCS:83036)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Vitamin d-3 level (HCPCS:82306)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Phosphate level (HCPCS:84100)
• Folic acid level, serum (HCPCS:82746)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Urine microalbumin (protein) level (HCPCS:82043)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Bacterial colony count, urine (HCPCS:87086)
• Iron level (HCPCS:83540)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Thyroid hormone, t3 measurement, free (HCPCS:84481)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Red blood count, automated test (HCPCS:85045)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Ferritin (blood protein) level (HCPCS:82728)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Liver function blood test panel (HCPCS:80076)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
• Blood test, clotting time (HCPCS:85610)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Screening 3d breast mammography (HCPCS:77063)
• Screening mammography (HCPCS:77067)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Bacterial culture for aerobic isolates (HCPCS:87077)
• Hepatitis c antibody screening, for individual at high risk and other covered indication(s) (HCPCS:G0472)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
• Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus (HCPCS:87637)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)

The enumeration date for this NPI number is 6/16/2006 and was last updated on 12/14/2011.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.